Clinical Trials Directory

Trials / Completed

CompletedNCT04090606

Tobacco Constituents and Biomarkers

Constituent Yields and Biomarkers of Exposure for Tobacco Product Regulation

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Masonic Cancer Center, University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This proposal addresses several research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products as mandated by the Family Smoking Prevention and Tobacco Control Act. Scientific evidence supports the important role of tobacco and cigarette smoke carcinogens in the development of cancers associated with cigarette smoking. Regulation of the levels of harmful constituents in cigarette smoke is one of the tobacco control strategies that now can be employed by the FDA and may serve to reduce tobacco carcinogen exposures in those smokers who are unable or unwilling to quit smoking. Such regulation will require a valid and robust approach to the assessment of comparative toxicity and carcinogenicity among various cigarette brands. This proposal will help develop a testing approach that can produce meaningful predictions of changes in human exposure due to changes in constituent levels in cigarette smoke, and hence serve as a reliable measure for product regulation. Thus, the proposed research will generate findings and data that are directly relevant to inform the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. The human trial deals with Aims 2 and 3 of this study.

Conditions

Interventions

TypeNameDescription
OTHERFTC Method Smoking Regimencigarettes are smoked by drawing 35 mL puff volumes over 2 s, with 60 s interval between puffs and no blocking of filter ventilation holes
OTHERMassachusetts Method Smoking Regimen45-mL puffs drawn over 2 s, with 30 s interval between puffs and 50% blocking of filter ventilation holes
OTHERHealth Canada Intense Smoking Regimen55-mL puff volumes of 2-s duration, with 30 s interval between puffs and 100% blocking of filter ventilation holes

Timeline

Start date
2013-12-01
Primary completion
2021-03-22
Completion
2021-03-22
First posted
2019-09-16
Last updated
2021-08-11

Source: ClinicalTrials.gov record NCT04090606. Inclusion in this directory is not an endorsement.